You just read:

Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the Transition of Christoph Lengauer, Ph.D., MBA, to a Newly Created Executive Vice President Role

News provided by

Blueprint Medicines Corporation

14 Nov, 2016, 16:01 ET